Education
About Us
Working with TipRanks
Follow Us
Matthew Lang Insider Profile
4 Followers
Matthew Lang, General Counsel & Corp. Secy. at Myovant Sciences, holds 162.50K shares in Lyell Immunopharma (Ticker: LYEL), holds 0.00 shares in Myovant Sciences (Ticker: MYOV).
Matthew Lang Myovant Sciences (MYOV)General Counsel & Corp. Secy.
Myovant Sciences (MYOV)
General Counsel & Corp. Secy.
Ranked #98,016 out of 100,956 Corporate Insiders
Profitable Transactions
2 out of 10 Profitable Transactions
Average Return
-67.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CBO
Roles that Matthew Lang holds in companies
Most Profitable Insider Trade
Stock:
Myovant Sciences
(MYOV)
(MYOV)
Rating:Informative Sell
Date:Jul 13, 2021 - Jul 13, 2022
Return:+33.30%
The most profitable trade made by Matthew Lang
Matthew Lang's Trading History
Myovant Sciences
Mar 10, 2023
―
Uninformative Sell
―
$0.00
Lyell Immunopharma
Feb 26, 2025
CBO
Uninformative Buy
―
$120.74K
List of latest transactions for each holding click on a transaction to see Matthew Lang's performance on stock
You May Also Like
Matthew Lang insider profile FAQ
What is the percentage of profitable transactions made by Matthew Lang?
The percentage of profitable transactions made by Matthew Lang is 20%.
What is the average return per transaction made by Matthew Lang?
The average return per transaction made by Matthew Lang is -67.70%.
What stocks does Matthew Lang hold?
Matthew Lang holds: MYOV, LYEL stocks.
What was Matthew Lang’s latest transaction?
Matthew Lang latest transaction was an Uninformative Buy of ―.
What was Matthew Lang's most profitable transaction?
Matthew Lang’s most profitable transaction was an Informative Sell of MYOV stock on July 13, 2021. The return on the trade was 33.30%.
What is Matthew Lang's role in Myovant Sciences?
Matthew Lang's role in Myovant Sciences is General Counsel & Corp. Secy..
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.